вход по аккаунту


Патент USA US3057896

код для вставки
United States Patent O?ice
Patented Oct. 9, 1962
or carboxylic acids (including derivatives thereof), and
include, inter alia, N-chloroacetamide.
The hypochlorous acid used for the conversion of the
Mun-steroids to the corresponding 9oc-ChlOI'O-1lj3-hY
droxy derivatives, may be employed as such or may be
Josef Fried, Princeton, N.J., and Josef E. Herz, Mexico
City, Mexico, assignors to Olin Mathieson Chemical
Corporation, New York, N.Y., a corporation of
formed in situ by interacting an N-chloro-amide or N
chloro-imide of a carboxylic acid (including derivatives
thereof) with water. Suitable N-chloro-amides and N
chloro-imides include N-chloroacetamide (or N-chloro
No Drawing. Filed Dec. 10, 1958, Ser. No. 779,302
5 Claims. (Cl. 260—397.45)
Serial No. 429,108, ?led May 11, 1954, now abandoned.
amides of other fatty acids), N-chlorosuccinimide (or
other cyclic imides of amino fatty acids), and N,N-di
chlorodimethylhydantoin. As previously stated, if such
This invention relates to a new process for synthesizing
an N-chl0r0~am-ide or N-chloro-imide is employed, water
This application-in-part of our parent application,
must be present in the reaction medium. The reaction
valuable steroids.
An object of this invention is the provision of an ad 15 medium preferably also includes an inert solvent for the
steroid reactant. Representative of such solvents are the
vantageous process of introducing a 9‘a-chloro and 115
tertiary alcohols (such as tertiary butanol), ethers (such
hydroxy radical into a Mun-steroid.
as acyclic ethers, e.g. diethyl ether and methyl isopropyl
The process of this invention essentially comprises
ether or cyclic ethers, e.g. dioxane), and certain ketones.
reacting a Mun-steroid with hypochlorous acid and re
Unless hypochlorous acid is used directly as the chlori
covering the product produced.
nating agent, the reaction is preferably eifected in the
Steroids useful as starting materials in the practice of
presence of a relatively strong acid. Although any strong
the process of this invention include the members of the
acid may be used, and acids such as sulfuric acid and
A9(11)-androstene (including the A9(11)-etiocholene) and
nitric acid are operative, it is preferred to conduct the
the A9<11)-pregnene ‘(including the A9(11)-a1lopregnene)
series; the preferred compounds belonging to the A901) 25 reaction in the presence of a strong acid whose anion
possesses low nucleophilicity. By operating in this Way,
pregnene series, which includes the A‘LQQU-pregnadiene
losses due to the formation of undesired 11/3-esters are
and A1’4'9<11)-pregnatriene compounds. The speci?cally
eliminated, and the final yield of the desired product is
increased. Suitable relatively strong acids include per
preferred compounds of the A9(11)-pregnene series are
those of the general formula:
chloric ‘acid, p-toluene sulfonic among others. It is noted
0 HzY
that the use of a relatively strong acid, such ‘as per
chloric acid, is advantageous in the preparation of chlori
nated IIB-hydroxy steroids generally (e.g. from A1102)
steroids also), since it gives higher yields of the chloro
35 ll?-hydroxy steroids because no by-product esters are
In many instances when a Mun-steroid is treated in
accordance with the process of this invention, a 90:,11/3
,dichloro derivative is formed as a by-product, and this
can be reduced by means of chromous chloride (or other
reducing agent capable of reducing compounds possessing
the 1,2- and 4,5-positions being double-bonded or satu
rated, wherein R is —H, R’ is -—OH, or together R and
(vicinal chlorine atoms, e.g. zinc and acetic acid, and
Raney nickel) to regenerate the Mun-steroid, and this
R’ is :0 or a group convertible thereto by hydrolysis
latter can then be separated from the desired 9a-chloro
(such as a ketal group‘); Y is —H, halogen, -——OH, or 45 ll?-oxygenated steroid. This reduction may be carried
——O‘R”'; and Z is either —H or (a)——-OH; vR’” is an
out in situ or in a separate operation.
organic radical such as an acyl radical (acetyl, benzoyl,
If the reaction is conducted in an aqueous medium, an
naphthoyl, etc.), an aliphatic radical (methyl, ethyl, etc.)
ll/i-hydroxy steroid is produced. To obtain an ll?-or
or an aralkyl radical (benZyl, phenethyl, etc.).
gano-oxy derivative, an anhydrous alcoholic or acid solu
The resulting compounds have the general formula: 50 tion is used. If methanol is substituted for water, an
ll?-methoxy compound is produced. If acetic acid is
substituted for water, an 11 [R-acetoxy compound is formed.
The following examples are illustrative of the inven
9a-Chl0rohydrocortisone Acetate (‘9u-Chl0r0-A4-Preg'nene
11,8,17a,21-Tri0l-3,20-Di0ne ZJ-Acetate) From A4,9(11)
Pregnadiene-1.7a,21 -Di0l-3,20-Di0ne 21-Acetate
246 mg. of ?nely pulverized A4’9(11)-pregnadiene 170:,21
diol-3,20-dione 2l-acetate is dissolved in 50 m1. of hot
dioxane and after adding 5 ml. of water, the solution
wherein the 1,2- and 4,5-positions are double-bonded or
is rapidly cooled to room temperature while agitating. To
saturated as before, and R, R’, Y, and Z are as hereinbe
65 the resulting suspension is added 268 mg. of N,N-di
fore identi?ed.
chlorodimethyl-hydantoin and 5 ml. of 1 N perchloric acid,
The steroids formed by the process of this invention are
and the reaction is ‘allowed to proceed at room tempera
highly active gluco- and minerolo-corticoids, as disclosed
ture for two and one-half hours. Excess N,N-dichloro
in US. Patent No. 2,852,511, granted September 16, 1958.
Suitable chlorinating agents for the conversion of Am”
steroids to the corresponding 9u-chloro-11?-hydroXy (or
ll?-organo-oxy) derivatives, are, for example, aqueous
hypochlorous acid, N-chloroamides or N-chloro—imides
dimethylhydantoin is then destroyed by the addition of
dilute aqueous sodium sul?te. 50 ml. of chloroform is
added, and the small aqueous phase ?oating on top is.
separated off. The chloroform-dioxane phase is washed
mixture is dilute with 25 ml. of chloroform which causes
separation into two layers. The chloroform-dioxane
with dilute sodium bicarbonate and with water and dried
over sodium sulfate.
Removal of the solvents in vacuo
phase is separated off, washed with water, sodium bicar
leaves a readily crystallizing residue (about 330 mg). A
small portion of the residue is recrystallized for analysis
from acetone, M.P. about 241° C. (dec.).
bonate and again with water, dried over sodium sulfate
and evaporated to dryness in vacuo. The resulting resi
due (about ‘128 mg), on recrystallization from acetone
Analysis.—Calcd. for C23H28O5Cl2 (455.36): C, 60.66;
H, 6.19; Cl, 15.57. Found (approximately): C, 60.88;
H, 6.60; Cl, 15.41.
The above compound represents 9a,11?-dichloro-A4
chloroform-hexane yields pure 9a-chloro-11B-17a-dihy
droxyprogesterone, M.P. about 246-2480 C. (dec). The
compound is identi?ed by infrared spectrum and mixture
melting point comparison with an authentic sample.
pregnene-l7a,2l-diol-3,20-dione 21 acetate. The total 10
Yield about 58 mg.
mixture obtained above is dissolved in 5 ml. dioxane and
treated at room temperature with 2 ml. of an aqueous
solution of chromous chloride [prepared as described in
the J. Am. Chem. Soc., 72, ‘4080 (1950)]. After 30
minutes the reaction mixture is aerated to oxidize the re
maining chromous chloride to chromic chloride and 20
9a-ChIor0-I I?-Hydroxyprogesterone From 1341901)
Pregrzadiene-S’ .ZO-Dimw
A solution of 103 mg. of A49(11)-pregnadiene-3,20-dione
in 20 ml. of dioxane and 2 ml. of water is treated with
100 mg. of N,N~dichlorodimethylhydantoin and 1 ml. of
l N perchloric acid as described above. The resulting
ml. of chloroform is added. After separation of the
layers, the chloroform-dioxane extract is washed with
water, dilute sodium bicarbonate, ‘and again with water
and ?nally dried over sodium sulfate. Removal of the
crystalline residue (about 140 mg.) is dissolved in 4 ml.
solvents in vacuo leaves a residue (about 286 mg.) which
of acetone and treated with 1 m1. of a chromous chloride
crystallizes spontaneously. Since this product is a mix
ture, it is chromatographed on 6 g. of silica gel. Elution
solution as described in Example 1. The work-up yielded
about 104 mg. of amorphous material which is dissolved
with chloroform yields A‘WuD-pregnadiene-17a,2l-diol¢
in 0.5 ml. of chloroform and 4 ml. of benzene and chro
matographed on 2 g. of silica gel. Elution of the column
3,2‘0-dione Zleacetate (about 1:10 mg.) which after re
with chloroform benzene 1:8 (230 ml.) affords about 35
crystallization from acetone melts at about 234~236° C.
mg. of A4-9(11>-pregnadiene—3,2O-dione. Subsequent elu
A mixture melting point with an authentic sample of
tion of the column with benzene chloroform 1:1 (300
that substance shows no depression. Subsequent elution
ml.) furnishes about 43 mg. of crude 9u-chloro-11[i—hy
of the column with 5% acetone in chloroform affords
9a-chloro-hydrocortisone acetate (about 100 mg.) which 30 droxyprogesterone, which after crystallization from ace
tone-hexane has the following properties: M.P. approxi
after crystallization, ?rst ‘from acetone-hexane and ?nally
mately 205° C. (dec.); [@1323 +199° (0., 0.59 in chloro
from acetone, melts at about 202° C. (dec.). Infrared
form). There is no depression in melting point when
comparison with an authentic sample of ‘9a-chlorohy
this material is mixed with an authentic sample of 9a—
drocortisone acetate shows the two to be identical.
35 chloro-l 1 ?-hydroxyprogesterone.
The above two reactions could be combined into a
Reaction of A4,“11)-Pregnadiene-1 7a,21-Di0l-3,20-Di0l1e
single work-up by adding the chromous chloride solution
21-Acetale With Hypochlorous Acid
directly to the initial reaction mixture after the destruc
To a suspension of 400 mg. of AHQD-pregnadiene-l7a, 40 tion of excess N,N-dichlorodimethylhydantoin with sodi
um sul?te, as described in the following example:
2l-diol-3,20-dione 21-acetate in 40 ml. of dioxane and
‘4 ml. of Water is added at room temperature 2.5 ml. of
an 0.61 N aqueous solution of hypochlorous acid (pre
From Air-“(11>
pared by saturating a 10% solution of sodium bicarbonate
with chlorine at 0° and adjusting the pH of the resulting 45
solution with sodium hydroxide to 6.7). The suspension
A solution of 103 mg. of A4-9(11>-pregnadiene-3,20-dione
clears within 2 minutes, and 20 minutes later excess hy
in 20 ml. of dioxane and 2 ml. of water is treated with
pochlorous acid is destroyed by the addition of sodium
100 mg. of N,N-dichlorodimethylhydantoin and 1 ml. of
sul?te solution. 150 ml. of chloroform is added, the
1 N perchloric acid as in Example 4. Excess N,N-di~
phases are separated and the chloroform solution washed 50 chlorodimethylhydantoin is then destroyed by the addi
with water. After drying over sodium sulfate the solvent
tion of dilute aqueous sodium sul?te. The mixture is
is removed in vacuo. The crystalline residue after several
diluted with 30 ml. of chloroform which causes separa
recrystallizations from acetone has the following prop
tion into two layers. The chloroform-dioxane phase is
erties: M.P. about 243—24-4° (dec.); [@1323 +164° (c.
separated off, washed with water, sodium bicarbonate,
107 in CHCl3);
55 and again with water; it is freed from chloroform by
vacuum concentration and treated with 2 ml. of a chrom
A553,, 238 mp. (e=15,600)
ous chloride solution as described in Example 1.
Analysis.—-—Calcd. for C23H30O5Cl2: C, 60.3; H, 6.62;
Cl, 15.55. Found: C, 60.36; H, 6.68; Cl, 13.38.
To obtain 9a-chlorohydrocortisone acetate, the total
reaction product is treated with chromous chloride and
the resulting mixture of A419(m-pregnadiene-l7u,21-diol
9a-Chlorocorticosterone Actate From A‘i-gun-Pregnad?
ene-21-0l-3,20-Di0ne 21—Acetalc
3,20-dione Ill-acetate and 9a-chlorohydrocortisone ace
tate separated by chromatography as described in Ex
ample 1.
9a-Chloro-115,17a-Dilzydroxyprogesterone From A4501)
Pregnadiene-J 7a-oI-3,20-Dione
110 mg. of n‘mun-pregnadiene-17a-ol-3,20-dione is
dissolved in 20 ml. of dioxane and 2 ml. of water is 70
added. To the resulting solution is added 100 mg. of
N,N-dichlorodimethylhydantoin and the mixture is al
lowed to stand at room temperature for 30 minutes.
Dilute aqueous sodium sul?te solution is added to de
work-up yields about 45 mg. of 9a-chloro-ll?-hydroxy
Following the process of Example 1, but substituting
A4'9(11)-pregnadiene - 21 - ol - 3,20 - dione
A6901)-pregnadiene-17a,21-diol-3,20-dione 2l-acetate, the
corresponding 9ot-chlorocorticosterone acetate is produced.
Following the process of Example 1, but substituting
A4-9<11>-pregnadiene1701,2l-diol-3,20-dione for the corre
sponding 2l-acetate, the compound 9ot-chloro-A4-preg
nene-11?,17a,21 - triol - 3,20-dione
stroy residual N,N-dichloro-dimethy1 hydantoin and the 75 acne) is produced.
wherein the carbon atoms in the ‘1,2 and 4,5 positions are
9a-Chl0r0prednis0lone Acetate From A1’4'9(11)-Pregnatri
joined by bonds selected from the group consisting of
single and double bonds, R is hydrogen, R’ is hydroxyl,
ene-J 711,21 -Di0l-3,20-Di0ne 21-Acetate
and when taken together R and R’ is selected from the
ground consisting of oxo and a group convertible thereto
Following the procedure of Example 1, but substitut
ing 240‘ mg. of Ale’gun-pregnatriene-17u,21-di0l-3,20~
by hydrolysis; Y is selected from the group consisting of
dione 21-acetate for the diene in the example, there is ob
hydrogen, hydroxy, halogen and the acyloxy radical of a
tained 9a-chloroprednisolone acetate.
hydrocarbon carboxylic acid of less than ten carbon
The invention may be variously otherwise embodied
atoms; and Z is selected from the group consisting of
within the scope of the appended claims.
hydrogen and a-hydroxy, to the corresponding 9u-Ch101‘0
What is claimed is:
ll?-hydroxy derivatives, which comprises reacting said
1. The process for converting a AND-steroid to a cor
unsaturated pregnene in the presence of water with N,N
dichlorodirnethylhydantoin in the presence of a strong
prises reacting said steroid with N,N-dichlorodimethylhy
dantoin in the presence of Water and a strong acid whose 15 acid whose anion possesses 10W nucleophilicity, and re
responding 9a-chloro-11/3-hydroXy steroid which com
anion possesses low nucleophilicity, and recovering said
covering the 9a-chloro-11?-hydroxy derivative.
9a-chloro-1/1/3-hydroxy steroid.
2. The process for converting A419(11>-pregnadiene-17a
ol-3,20-dione to 9a-chloro-1l5,l7ot-dihydroxyprogesterone
which comprises reacting said pregnadiene with N,N-di
5. The process for converting a 21-ester of A4190”
pregnadiene-l7a,2l-diol-3,20-dione and a hydrocarbon
carboxylic acid of less than ten carbon atoms to the cor
responding 21-ester of 9a-chlorohydrocortisone, which
chlorodimethylhydantoin in the presence of water and a
strong acid whose anion possesses low nucleophilicity and
comprises reacting said pregnadiene in the presence of
perchloric acid with N,N-dichlorodimethylhydantoin in
recovering 9u-chloro-11/3,l7a-dihydroxyprogesterone.
the presence of water, dechlorinating a polychlorinated
3. The process for converting A4I9(11>-pregnadiene-3,20
dione to 9u-chloro-1l?-hydroxyprogesterone which com
prises reacting said pregnadiene with N,N-dichlorodi
methylhydantoin in the presence of water and a strong
acid whose anion possesses low nucleophilicity, dechlo
rinating a polychlorinated by-product formed thereby, and
recovering 9a-chlor0-1 l?-hydroxyprogesterone.
by-product formed thereby by treatment with chromous
chloride, and recovering the 9a-chlorohydrocortisone pro
4. The process for converting a A9(11)-pregnene of the
References Cited in the ?le of this patent
general formula:
Farrar _______________ _- Apr. 26, 1955
Schneider ____________ __ June 19, 1956
Campbell et a1 _________ __ June 10, 1958
Fried _______________ __ Sept. 16, 1958
Rosenkranz et al.: I. Am. Chem. Soc., vol. 72 (‘1950),
page 4080.
Fried et al.: J. Am. Chem. 800., volume 75 (May 5,
1953), pages 2273 and 2274,
Patent No» 3qO57y886
October 9Y 1962
Josef Fried et a1°
It is hereby certified that error appears in the above numbered pat
ent requiring correction and that the said Letters Patent should read as
corrected below.
Column 1, line 11, for "application-impart" read
-~— application is a continuati0n-—in—part ——; column Ll‘I line
61,, for ‘*Actate'? in italics? read —— Acetate ——D in
Signed and sealed this 22nd ‘day of October 1963°
Attesting Officer
AC ting Commissioner of Patents
Без категории
Размер файла
445 Кб
Пожаловаться на содержимое документа